PP
TMO icon

Paloma Partners’s Thermo Fisher Scientific TMO Stock Holding History

Paloma Partners’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-1,900
Closed -$1.05M – 1671
2024
Q2 		$1.05M Buy
+1,900
New +$1.09M 0.03% 502
2024
Q1 		– Sell
-7,100
Closed -$3.77M – 1050
2023
Q4 		$3.77M Sell
7,100
-400
-5% -$194K 0.14% 163
2023
Q3 		$3.8M Buy
7,500
+2,900
+63% +$1.55M 0.13% 141
2023
Q2 		$2.4M Buy
+4,600
New +$2.48M 0.09% 219
2023
Q1 		– Sell
-2,300
Closed -$1.27M – 979
2022
Q4 		$1.27M Buy
+2,300
New +$1.22M 0.06% 314
2019
Q2 		– Sell
-4,100
Closed -$1.12M – 2172
2019
Q1 		$1.12M Buy
4,100
+1,800
+78% +$448K 0.03% 672
2018
Q4 		$515K Sell
2,300
-29,100
-93% -$6.83M 0.02% 663
2018
Q3 		$7.66M Buy
+31,400
New +$7.22M 0.14% 108
2018
Q2 		– Sell
-29,700
Closed -$6.13M – 2194
2018
Q1 		$6.13M Buy
+29,700
New +$6.23M 0.1% 152
2017
Q4 		– Sell
-32,500
Closed -$6.15M – 2300
2017
Q3 		$6.15M Sell
32,500
-40,200
-55% -$7.28M 0.08% 230
2017
Q2 		$12.7M Buy
+72,700
New +$12.2M 0.15% 97

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Paloma Partners's TMO Position: Q4 2024 in Review

Paloma Partners sold out of Thermo Fisher Scientific (TMO) in Q4 2024, closing a stake of 1,300 shares — an estimated $804K sold.

Paloma Partners first reported a position in TMO in Q2 2013 and held it in 32 quarters. The position peaked at $18.4M in Q1 2021. 2,616 funds tracked by Wall St. Rank hold TMO as of Q4 2024.

  • Paloma Partners reported no remaining Thermo Fisher Scientific position as of Q4 2024 after selling out during the quarter.
  • Paloma Partners sold 1,300 Thermo Fisher Scientific shares in Q4 2024, an estimated $804K.
  • Paloma Partners first reported a position in Thermo Fisher Scientific in Q2 2013 and held it in 32 quarters.
  • Paloma Partners's Thermo Fisher Scientific position peaked at $18.4M in Q1 2021.
  • 2,616 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q4 2024.

Based on Paloma Partners's 13F filing for Q4 2024, filed 14 Feb 2025.